- Home
- NCO vs MIST Comparison
NCO vs MIST Comparison
Compare NCO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.05
Company Overview
Basic Information| Metric | NCO | MIST |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Canada |
| Employees | N/A | 38 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.1M | 131.3M |
| IPO Year | 2026 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NCO | MIST |
|---|---|---|
| Price | $9.87 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 179.1K | ★ 1.6M |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.83 | $1.00 |
| 52 Week High | $9.88 | $3.06 |
Technical Indicators
Market Signals| Indicator | NCO | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 39.37 |
| Support Level | $9.85 | $1.01 |
| Resistance Level | N/A | $1.42 |
| Average True Range (ATR) | 0.01 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 57.14 | 9.26 |
Price Performance
Historical Comparison NCO
MIST
About NCO Southern Cross Acquisition I Corp. Ordinary Shares
Southern Cross Acquisition I Corp is a blank check company formed for the purpose of effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.